These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 1698017
61. [Concomitant pulmonary Langerhans cell histiocytosis and malignant lymphoma: report of two cases]. Régis A, Ben Salem D, Lambert A, Couaillier JF, Casasnovas O, Piard F, Krausé D. J Radiol; 2009 Jan; 90(1 Pt 1):66-8. PubMed ID: 19182717 [No Abstract] [Full Text] [Related]
62. Thymic hyperplasia in adults following chemotherapy for malignancy. Simmonds P, Silberstein M, McKendrick J. Aust N Z J Med; 1993 Jun; 23(3):264-7. PubMed ID: 7688954 [Abstract] [Full Text] [Related]
63. Persistent paraneoplastic neurologic syndrome after successful therapy of Hodgkin's disease. Maslovsky I, Volchek L, Blumental R, Ducach A, Lugassy G. Eur J Haematol; 2001 Jan; 66(1):63-5. PubMed ID: 11168510 [Abstract] [Full Text] [Related]
64. PET-positive bone lesion due to Langerhans cell histiocytosis after BEACOPP therapy for Hodgkin lymphoma: how anamnesis, histopathological accuracy, and molecular analysis could resolve a clinical dilemma. Haefliger S, Bihl M, Krasniqi F, Tzankov A. Ann Hematol; 2018 Feb; 97(2):355-357. PubMed ID: 28975389 [No Abstract] [Full Text] [Related]
65. [Primary Hodgkin disease of the lung]. Anchisi S, Pugin P, Baur A. Schweiz Med Wochenschr; 1993 Jan 23; 123(3):65-6. PubMed ID: 7678941 [Abstract] [Full Text] [Related]
67. Agreement rates among single photon emission computed tomography using gallium-67, computed axial tomography and lymphangiography for Hodgkin disease and correlation of image findings with clinical outcome. Ha CS, Choe JG, Kong JS, Allen PK, Oh YK, Cox JD, Edmund E. Cancer; 2000 Sep 15; 89(6):1371-9. PubMed ID: 11002233 [Abstract] [Full Text] [Related]
68. Twelve years of experience with cytotoxic therapy in malignant tumors of the neck and head. Bartual J, Roquette J, Gil M, Magro E, Bascuas JL. Arch Otorhinolaryngol; 1982 Sep 15; 234(3):305-12. PubMed ID: 6180720 [Abstract] [Full Text] [Related]
69. Chemotherapy treated Hodgkins disease--a fifteen year review. Bourke JP, Fennelly JJ, Duggan J, Boyle E, McCabe M, Warde P, Conroy R. Ir J Med Sci; 1986 Sep 15; 155(9):300-7. PubMed ID: 3771168 [No Abstract] [Full Text] [Related]
76. Pancytopenia with myelofibrosis. An unusual presentation of childhood Hodgkin's disease. Carroll WL, Berberich FR, Glader BE. Clin Pediatr (Phila); 1986 Feb 15; 25(2):106-8. PubMed ID: 3753669 [No Abstract] [Full Text] [Related]
77. Is anything better than MOPP? Longo DL. Hematol Oncol; 1993 Feb 15; 11(2):65-71. PubMed ID: 8406376 [No Abstract] [Full Text] [Related]
78. High dose chemotherapy with stem-cell transplantation in a metastatic medulloblastoma in an adult: a case report and review of the literature. Cottu PH, Giacchetti S, Mignot L, Epardeau B, Visot B, Extra JM, Espie M, Marty M. J Neurooncol; 1994 Feb 15; 18(1):19-23. PubMed ID: 7520058 [Abstract] [Full Text] [Related]
79. Current management and controversies. The chemotherapist's view. Lemerle J, Oberlin O. Cancer Treat Res; 1989 Feb 15; 41():129-43. PubMed ID: 2577071 [No Abstract] [Full Text] [Related]
80. Paraneoplastic cerebellar degeneration: a rare presentation of Hodgkin's disease. Krishnan K, Bockenstedt P. Clin Lab Haematol; 1994 Dec 15; 16(4):359-62. PubMed ID: 7537642 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]